NCT05892380View on ClinicalTrials.gov

The Clinical Value of an Artificial Intelligence System Using Abbreviated Protocol of Breast MRI Facilitates Classification of Breast Lessions

UnknownOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

May 1, 2025

Study Completion Date

August 1, 2025

Conditions
Breast Cancer
Trial Locations (1)

200032

Fudan university Shanghai Cancer Center, Shanghai

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Fudan University

OTHER